By gaining access to the huge amount of lactate released as a waste product by other cancer and stromal cells, MCT1 helps these glutamine-starved PDAC cells to exploit a metabolite that is excessively available and can be readily as well as variably metabolized [83]. Here, SLC16A1 is linked to cancer.